Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ionis Pharmaceuticals (IONS) -- Ignore unavailable to you. Want to Upgrade?

To: growthvalue who wrote (2211)	8/20/1998 3:38:00 PM
From: David Bogdanoff	Read Replies (1) \| Respond to of 4676

G; I certainly would like to see a move up, but doubt that indications of efficacy that can come from a phase II trial don't seem to do the trick. Investors seem to expect alot these days; we didn't get a sustained move even with the recent FDA approval, which showed an important proof of principal. However, the main point of my last post was that the timeline for (hopefully) encouraging news was over a year. David